BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2653074)

  • 1. Adrenoleukodystrophy and other peroxisomal disorders that affect the nervous system, including new observations on L-pipecolic acid oxidase in primates.
    Moser HW; Mihalik SJ; Watkins PA
    Brain Dev; 1989; 11(2):80-90. PubMed ID: 2653074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal adrenoleukodystrophy. Impaired plasmalogen biosynthesis and peroxisomal beta-oxidation due to a deficiency of catalase-containing particles (peroxisomes) in cultured skin fibroblasts.
    Wanders RJ; Schutgens RB; Schrakamp G; Tager JM; Van den Bosch H; Moser AB; Moser HW
    J Neurol Sci; 1987 Feb; 77(2-3):331-40. PubMed ID: 3819771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroxisomal disorders; newer concept and recent studies].
    Kamoshita S
    Nihon Rinsho; 1990 Mar; 48(3):629-38. PubMed ID: 2192101
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenoleukodystrophy and Zellweger syndrome.
    Moser HW; Moser AB; Chen WW; Watkins PA
    Prog Clin Biol Res; 1990; 321():511-35. PubMed ID: 2183241
    [No Abstract]   [Full Text] [Related]  

  • 6. Peroxisomal disorders.
    Gordon N
    Brain Dev; 1987; 9(6):571-5. PubMed ID: 3328519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
    Hoefler G; Hoefler S; Watkins PA; Chen WW; Moser A; Baldwin V; McGillivary B; Charrow J; Friedman JM; Rutledge L
    J Pediatr; 1988 May; 112(5):726-33. PubMed ID: 2452243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
    Singh I; Moser AE; Goldfischer S; Moser HW
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal and perinatal diagnosis of peroxisomal disorders.
    Schutgens RB; Schrakamp G; Wanders RJ; Heymans HS; Tager JM; van den Bosch H
    J Inherit Metab Dis; 1989; 12 Suppl 1():118-34. PubMed ID: 2509803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisomal disorders in neurology.
    Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
    J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New approaches in peroxisomal disorders.
    Moser HW
    Dev Neurosci; 1987; 9(1):1-18. PubMed ID: 3297624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peroxisome: nervous system role of a previously underrated organelle. The 1987 Robert Wartenberg lecture.
    Moser HW
    Neurology; 1988 Oct; 38(10):1617-27. PubMed ID: 2458548
    [No Abstract]   [Full Text] [Related]  

  • 14. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
    Brown FR; Voigt R; Singh AK; Singh I
    Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked adrenoleukodystrophy: defective peroxisomal oxidation of very long chain fatty acids but not of very long chain fatty acyl-CoA esters.
    Wanders RJ; van Roermund CW; van Wijland MJ; Nijenhuis AA; Tromp A; Schutgens RB; Brouwer-Kelder EM; Schram AW; Tager JM; van den Bosch H
    Clin Chim Acta; 1987 Jun; 165(2-3):321-9. PubMed ID: 3652454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy.
    Hashmi M; Stanley W; Singh I
    FEBS Lett; 1986 Feb; 196(2):247-50. PubMed ID: 3948997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
    Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
    Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal disorders. A review of a recently recognized group of clinical entities.
    Talwar D; Swaiman KF
    Clin Pediatr (Phila); 1987 Oct; 26(10):497-504. PubMed ID: 2443295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
    Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisomal disorders.
    Moser HW; Bergin A; Cornblath D
    Biochem Cell Biol; 1991 Jul; 69(7):463-74. PubMed ID: 1724376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.